Strain Information | |
---|---|
Image | |
BRC No. | RBRC02573 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6.129-Traf5<tm1Hna> |
Former Common name | B6.traf5<-/->, TRAF5 KO,C57BL/6 |
H-2 Haplotype | |
ES Cell line | R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>] |
Background strain | |
Appearance | black [a/a B/B C/C] |
Strain development | Developed by Drs. Hiroshi Nakano and Haruhio Koseki in 1999. |
Strain description | Homozygous mutant mice show defects in lymphocyte activation. |
Colony maintenance | Sibling Mating (Homozygote x Homozygote)Homozygous mutant mice are viable and fertile. |
References | J. Immunol., 172, 4292-4297 (2004). 15034043 Proc. Natl. Acad. Sci. USA, 96, 9803-9808 (1999). 10449775 J. Biol. Chem., 276, 36530 (2001) 11479302 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter neoneomycin resistance gene (E. coli)1neo; neomycin;herpes simplex virus thymidine kinase promoter (HSV tk promoter) |
Ordering Information | |
---|---|
Donor DNA | E. coli neo, mouse traf5 genomic DNA, herpes simplex virus thymidine kinase promoter (HSV tk promoter) |
Research application | Immunology and Inflammation Research |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. The recipient of BIOLOGICAL RESOURCE must obtain a prior written consent on use of it from the DEPOSITOR/DEVELOPER. |
Depositor | Hiroyasu Nakano (Juntendo University) |
Strain Status | Frozen embryos |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
Wang L, Lu Y, Guan H, Jiang D, Guan Y, Zhang X, Nakano H, Zhou Y, Zhang Y, Yang L, Li H. Tumor necrosis factor receptor-associated factor 5 is an essential mediator of ischemic brain infarction. J Neurochem 126(3) 400-14(2013) 23413803 |